Skip to main content
Equibles

GSA CAPITAL PARTNERS LLP

Position in OCGN — Ocugen, Inc.

CIK 1362033 LONDON, X0
Back to OCGN Full portfolio

Position in OCGN

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$138,663
-$1,056,246 QoQ
Shares Held
90,630
-89.8% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#62
of 147 holders
Holding Since
Jun 2021
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in OCGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GSA CAPITAL PARTNERS LLP holds $104,909,103 across 164 Biotechnology names. OCGN ranks #137 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IOVA
Iovance Biotherapeutics, Inc.
 655,318 $2,726,122
2 IMVT
Immunovant, Inc.
 65,267 $2,514,737
3 GOSS
Gossamer Bio, Inc.
 187,337 $2,472,846
4 AXSM
Axsome Therapeutics, Inc.
 9,419 $2,305,488
5 CABA
Cabaletta Bio, Inc.
 668,563 $2,079,230
6 MLTX
MoonLake Immunotherapeutics
 106,695 $2,077,351
7 ATYR
aTYR PHARMA INC
 3,454,863 $2,062,553
8 CORT
Corcept Therapeutics Inc
 23,257 $2,022,196

All Filings in OCGN

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $138,663 90,630
2025-12-31 $1,194,909 885,118
2025-09-30 $1,697,804 1,041,598
2025-06-30 $1,676,704 1,728,561
2025-03-31 $1,156,451 1,638,033
2024-12-31 $922,315 1,145,733
2024-09-30 $202,675 204,310
2023-12-31 $33,419 58,120
2022-06-30 $28,595 12,597
2022-03-31 $103,478 31,357
2021-12-31 $71,516 15,718
2021-06-30 $138,509 17,249